Carcinogenesis

Key developments

1929–1958

Foundation of Multi-Stage Carcinogenesis

Cancer research coalesced around a multi-stage framework linking sequential cellular events to cancer incidence. Pathology-driven taxonomy integrated histopathology with tumor biology to establish unified classifications across organ sites. Experimental chemical induction using agents like benzpyrene provided foundational mechanistic models of initiation and progression. Systematic studies of metastasis and cellular changes anchored the centrality of systemic spread and clonal evolution in cancer progression.

Period 1929-1958: Pathology unified cancer classifications, metastasis patterns were mapped, liver niche biology emerged, and chemical induction modeled carcinogenesis. Multi-stage theory, cellular origin concepts, in vitro transformation, and systematic autopsy metastatic studies shaped modern cancer biology.

1959–1998

Molecular Genetics and Oncogenic Drivers

Research coalesced around molecular genetics, establishing oncogene amplification and protein kinase C signaling as central drivers of transformation. Investigators uncovered the role of apoptosis and transplacental carcinogenesis while linking HER-2 amplification to breast cancer survival. Studies then converged on p53 as a universal tumor suppressor governing cell cycle control and programmed cell death. Tumor-derived VEGF signaling also gained prominence, illuminating angiogenesis as a critical axis in cancer biology.

Period 1959-1988: Oncogene amplification, T24 sequencing, metastasis studies, and xenograft models advanced molecular genetics. PKC signaling, apoptosis, epidemiological risk, HER-2/neu, and stilbestrol shaped modern oncology. Period 1989-1998: Mutations in p53 drive carcinogenesis while wild-type p53 controls cell cycles and apoptosis, alongside c-Myc cross-talk, VEGF angiogenesis, and apoptotic therapies, mapping genetic etiologies. These foundational findings established p53 as a universal tumor suppressor, linked Wnt signaling to colon cancer, and identified endogenous anti-angiogenic inhibitors.

1999–2005

Networked Hallmarks of Carcinogenesis

Cancer research coalesced around a network- and pathway-centric paradigm driven by the Hallmarks of Cancer framework. Cell death and autophagy emerged as tumor-suppressive gatekeepers regulating tumorigenesis and therapy resistance. Dysregulated signaling networks, including PI3K–AKT, EGFR, BRAF, and Wnt axes, directed cellular proliferation and survival. These molecular insights combined with systems-level modeling and the Warburg effect to catalyze precision oncology.

Period 1999-2005: Apaf-1 and Beclin-1 regulated apoptosis and autophagy, while PI3K-AKT, EGFR, Stat3, Wnt-catenin, AXIN1, and BRAF signaling, p53 networks, and Globocan epidemiology drove cancer modeling. Seminal hallmarks, Warburg glycolysis, PI3K-AKT, BRAF, and EGFR frameworks catalyzed systems biology and precision oncology.

2006–2024

MicroRNA Networks and Tumor Ecosystem Plasticity

Post-transcriptional regulation and cellular plasticity initially defined tumor survival through microRNA networks and p53-regulated axes. Extracellular vesicles and matrix remodeling further illuminated mechanisms of progression within the tumor microenvironment. Subsequent research reframed cancer as an integrated ecosystem driven by immune evasion and metabolic rewiring. Large-scale genomic analyses and refined molecular subtyping ultimately enabled precision strategies and ecosystem-aware therapies.

Period 2006-2012: MicroRNA networks and p53 axes coordinated autophagy, apoptosis, EMT plasticity, and stem-like states to drive tumor progression. Foundational discoveries on miRNA signatures, microvesicle RNA transfer, MMP extracellular matrix remodeling, and cachexia criteria shaped subsequent cancer biology research. Period 2013-2024: Stromal heterogeneity, checkpoint pathways, noncoding RNA networks, and metabolic vulnerabilities drive cancer progression and translation. Updated hallmarks, mutation catalogues, cell death nomenclature, and molecular subtyping reshape precision oncology.

Explore the full timeline

Key figures

Foundation of Multi-Stage Carcinogenesis era

Otto Warbürg and 3 others

Otto Warbürg conducted investigations while affiliated with the National Cancer Institute and the National Institutes of Health. Through the publication of On the Origin of Cancer Cells, he advanced the multi-stage framework by linking cellular metabolic shifts to the fundamental origins and progression of cancer. Herbert L. Abrams performed research while based at Stanford University and the University of California, San Francisco. In Metastases in carcinoma.Analysis of 1000 autopsied cases, he contributed to the multi-stage framework by providing systematic evidence regarding the frequency and patterns of systemic spread in cancer progression. Norman Goldstein contributed to this field while working at the Mayo Clinic and Argonne National Laboratory. His work in Metastases in carcinoma.Analysis of 1000 autopsied cases supported the multi-stage framework by reinforcing the clinical understanding of metastatic dissemination across organ sites. Robert Spiro carried out his studies while associated with the Montefiore Medical Center. Through Metastases in carcinoma.Analysis of 1000 autopsied cases, he helped establish the foundational role of metastasis in multi-stage carcinogenesis and tumor biology.

Molecular Genetics and Oncogenic Drivers era

Richard Peto and Richard Doll

Richard Peto, working at the University of Oxford and the John Radcliffe Hospital, contributed to the understanding of molecular genetics and oncogenic drivers. Through The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today, this work provided foundational quantitative estimates that helped clarify the landscape of cancer risks and transformation factors. Richard Doll, affiliated with the University of Oxford and Statistical Research (United States), also advanced this central theme of the era. By co-authoring The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today, this research helped shape broader epidemiological frameworks essential to evaluating environmental and genetic drivers of carcinogenesis.

Networked Hallmarks of Carcinogenesis era

Bert Vogelstein and 2 others

Bert Vogelstein, working at the Howard Hughes Medical Institute and Johns Hopkins University, advanced our understanding of molecular signaling networks. Through the publication Surfing the p53 network, this work mapped how critical tumor-suppressive pathways regulate cellular proliferation and survival within the cancer hallmark framework. Arnold J. Levine, affiliated with the Rockefeller University and the Institute for Advanced Study, further elucidated these gatekeeping mechanisms. Through the publication Surfing the p53 network, this research integrated complex regulatory circuits into the broader paradigm of networked carcinogenesis. David P. Lane, conducting research at the University of Dundee and Ninewells Hospital, contributed significantly to this pathway-centric framework. Through the publication Surfing the p53 network, this investigation detailed how p53 network interactions govern tumor suppression and cellular stress responses.

MicroRNA Networks and Tumor Ecosystem Plasticity era

Marcus E. Peter and 3 others

Marcus E. Peter conducted research while affiliated with the University of Chicago and Northwestern University. Through the paper The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2, this work advanced post-transcriptional regulation and cellular plasticity by defining how microRNA networks determine cancer cell phenotypes. Ernst Lengyel performed investigations at the University of Chicago and the Gynecologic Oncology Group. Through the paper The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2, this researcher contributed to microRNA networks and tumor survival mechanisms via targeted regulation of epithelial phenotypes. Sun-Mi Park undertook studies at the University of Chicago and the May Institute. Through the paper The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2, this investigator illuminated post-transcriptional regulation and cellular plasticity by identifying key targets within microRNA networks. Arti Gaur advanced scientific understanding while working at Dartmouth College and the Dartmouth–Hitchcock Medical Center. Through the paper The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2, this work illuminated mechanisms of tumor survival and cellular plasticity through the action of the miR-200 family.

References

Key developments

Molecular Genetics and Oncogenic Drivers

MicroRNA Networks and Tumor Ecosystem Plasticity